Reducing risk of breast cancer recurrence and death with increased dose density

Breast cancer therapy resistance mediated by FGFR amplification

The significance of CEACAM 5 in metastases of triple negative breast cancer

Results of the MONALEESA 7 trial

The REACT trial: Celecoxib vs placebo for primary breast cancer

Rationale and recruitment in the PARTNER trial

The role of axiliary node dissection in modern breast cancer surgery

Anastrozole duration for post-menopausal breast cancer patients after 5 years of endocrine therapy

ER positive breast cancer: Screening for clinical variables to predict late distance disease recurrence

Predicting late breast cancer recurrence with screening assays

The SOFT trial: Comparing adjuvant tamoxifen with ovarian function suppression via exemestane to tamoxifen alone

CDK 4/6 inhibitors for older women with HR-positive breast cancer